Change of Adviser Name

RNS Number : 3399F
Advanced Medical Solutions Grp PLC
08 October 2008
 



For Immediate Release                                                                              08 October 2008 



Advanced Medical Solutions Group PLC

('AMS' or the 'Company')


Change of Broker and Nominated AdviseName



Following its change of name from Landsbanki Securities (UK) Limited to Teathers Limited on 7 October 2008, the name of the Company's broker and nominated adviseis now Teathers Limited of: 

  

Beaufort House 

15 St Botolph Street 

London EC3A 7QR.


Enquiries


For further information, please contact:


Advanced Medical Solutions Group plc


Don Evans, Chief Executive Officer

Mary Tavener, Finance Director

www.admedsol.com

Tel : +44 (0) 1606 545508



Buchanan Communications


Mark Court, Mary-Jane Johnson, Stasa Filiplic

Tel: +44 (0) 20 7466 5000



Teathers Limited

Tel: +44 (0) 20 7426 9000

Shaun Dobson, Claes Spång



Notes to Editors:


Advanced Medical Solutions is a leading company in the development and manufacture of products for the $15 billion global woundcare market.

Founded in 1991 and quoted on AIM, Advanced Medical Solutions is focused on the design, development and manufacture of innovative and technologically advanced woundcare products.

In-house natural and synthetic polymer technology is used to provide advanced wound dressings based on the moist healing principle. AMS' resources ensure a unique position as a vertically integrated 'one stop shop' to provide all categories of moist wound healing products. The Company has the capability to move a product from design and development through to production and delivery for distribution and sale into customer markets.

The acquisition of 49.4% of Corpura BV in May 2008 strengthened AMS' position in hydrophilic polyurethane foam - the largest and fastest growing segment of the advanced woundcare market


AMS' technology in cyanoacrylate based tissue adhesives is used either for the closure of small cuts and trauma wounds through to large surgical incisions, or for protecting or sealing skin to prevent breakdown or infection. 

AMS' products currently serve the majority of the key global markets sold either direct or through strategic partners or distributors.



This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
APPFKFKQOBDKKKK
UK 100